Medicine & Health

Bursky Public Health and Brown School teams surveyed nearly 2,900 participants and co-developed retailer training to boost nutrition access during pregnancy and early childhood.

WashU Medicine researchers led a clinical trial testing three diets with different proportions of fat and carbohydrates and found all of them improved metabolic health, but a ketogenic plan had additional benefits for liver health and blood sugar control.

WashU clinical psychologist Kirk Dougher says new students need to learn how to manage stress, navigate the healthcare system and grow into a person who can handle what comes next. Parents can help by showing support while encouraging their child to take the lead in their own healthcare.

Jeffrey I. Gordon, MD, the Dr. Robert J. Glaser Distinguished University Professor at WashU Medicine, has received the Gabbay Award from Brandeis University in recognition of his outstanding contributions to the field of gut microbiome research.

A clinical trial co-led by WashU Medicine researchers found that adding family-based behavioral treatment to specialized pediatric care helped nearly half of children with obesity reach a healthier weight.

A new study led by WashU Medicine researchers including Jeffrey I. Gordon, MD, suggests that an intestinal disorder linked to malnutrition and stunted growth may be transmitted from one generation to the next via the small intestine’s microbiome.

Nathan Jacobs, a computer scientist at WashU McKelvey Engineering, and collaborators plan to develop a geospatial artificial intelligence tool to find early signs of instability in crop production.

Aaron Norris, MD, PhD, at WashU Medicine, has received a five-year $3.5 million NIH grant to study brain cells that regulate how the body burns calories and could lead to new ways to promote weight loss.

WashU Medicine serves as the official medical provider — and more — at the Greater St. Louis Marathon.

WashU Medicine researchers found that stopping GLP-1 drugs such as semaglutide and tirzepatide — even temporarily — elevates the risk of heart attack, stroke and death compared to staying on the medication continuously.